Curr Urol Rep (2014) 15:377 DOI 10.1007/s11934-013-0377-y

KIDNEY DISEASES (G CIANCIO, SECTION EDITOR)

Perioperative Complications of Robot-Assisted Partial Nephrectomy Eric H. Kim & Jeffrey A. Larson & Michael Figenshau & R. Sherburne Figenshau

Published online: 17 December 2013 # Springer Science+Business Media New York 2013

Abstract The incidence of renal cell carcinoma continues to increase with utilization of diagnostic abdominal imaging with migration towards a proportionally greater detection of small renal masses (SRM). Robot-assisted partial nephrectomy (RAPN) has become an attractive minimally invasive treatment modality for SRM’s due to the technical advantages and shortened learning curve compared to laparoscopic partial nephrectomy (LPN) while preserving comparable perioperative outcomes. With advances in ablative approaches for stage I renal cell carcinoma (RCC) and controversy surrounding the role of extirpative surgery for SRM’s, systematic understanding of the complications associated with RAPN has become even more imperative. This review aims to summarize and evaluate the contemporary literature, compile reported intraoperative complications, describe conventional and nephronsparing surgery (NSS) specific postoperative complications, and assess factors associated with an increased likelihood for perioperative complications following RAPN. Keywords Robot-assisted partial nephrectomy . RAPN . Robotic partial nephrectomy . Partial nephrectomy . Nephrectomy . Nephron-sparing surgery . NSS . Partial nephrectomy complication . Laparoscopic partial nephrectomy complication . Minimally-invasive complication . Da Vinci This article is part of the Topical Collection on Kidney Diseases E. H. Kim : J. A. Larson : M. Figenshau : R. S. Figenshau (*) Division of Urologic Surgery, Washington University School of Medicine, 4960 Children’s Place, Campus Box 8242, Saint Louis, MO 63110, USA e-mail: [email protected]

Introduction Due to the increased utilization of diagnostic abdominal imaging in recent years, the incidence of renal cell carcinoma (RCC) continues to increase. The American Cancer Society predicts 65,150 new RCC cases and 13,680 RCC deaths in the United States in 2013 [1]. There has also been proportionally greater detection of stage I disease and migration towards smaller tumor size within this stage [2]. In light of evidence that nephron-sparing surgery (NSS) provides favorable oncologic outcomes [3] and that radical nephrectomy (RN) is associated with significant morbidity and mortality [4], the American Urological Association (AUA) guidelines currently recommend partial nephrectomy (PN) as the standard of care for T1a tumors and as an alternative treatment for T1b tumors [5]. Robot-assisted partial nephrectomy (RAPN) has become a wide spread NSS modality because of the shortened learning curve compared to laparoscopic partial nephrectomy (LPN) [6] while achieving comparable perioperative outcomes [7]. With advances in ablative approaches for stage I RCC and recent controversy surrounding the role of extirpative surgery for small renal masses, systematic understanding of the complications associated with RAPN has become even more imperative. This review aims to summarize and evaluate the contemporary literature; compile reported intraoperative complications; describe conventional and NSS-specific postoperative complications; and assess factors associated with an increased likelihood for perioperative complications following RAPN.

E. H. Kim e-mail: [email protected]

Contemporary Series

J. A. Larson e-mail: [email protected]

As experience with RAPN has grown, studies successively updating single and multi-institutional perioperative complication rates of RAPN have been published. Table 1 summarizes contemporary studies with greater than 100 RAPN cases

M. Figenshau e-mail: [email protected]

377, Page 2 of 7

and their associated perioperative complication rates. In studies where complications were not categorized by ClavienDindo grade [8], we have attempted to do so based on the information provided. Although some more recent studies likely incorporate data from previously published reports, eliminating this redundancy was not feasible or substantively illustrative. Overall, RAPN is safe with reported intraoperative complication rates ranging from 1.4 % to 2.9 %, Clavien grade 1-2 postoperative complication rates ranging from 3.1 to 22.5 %, and Clavien grade 3-4 postoperative complication rates ranging from 2.0 % to 10.4 % [9••, 10–16]. Only one perioperative mortality occurred among all of the published studies [15]. Tanagho et al., have published the largest series to date with 886 patients included in their analysis. They report an intraoperative complication rate of 2.6 %, conversion rate of 0.8 %, and major (Clavien >3) postoperative complication rate of 3.6 % [9••]. This study is representative of the collection of contemporary series in Table 1. Generally, intraoperative complications are few, with intraoperative conversion to RN or to non-robotic PN even fewer. Additionally, minor postoperative complications (Clavien 1 and 2) were more common than major postoperative complications (Clavien 3 and 4). Death (Clavien 5 complication) in the postoperative period following RAPN was exceedingly rare. Conversion to other PN techniques and conversion to RN were not considered to be intraoperative complications by some authors. Spana et al., reported eight intraoperative complications, although they also reported six conversions to robotic RN that were not included as complications [12]. Scoll et al., and Rogers et al., report conversion rates to non-robotic PN modalities without specific mention of intraoperative complication rates [15, 16]. The seemingly broad range among postoperative complication rates are likely a result of under-reporting on the part of some studies. In studies where postoperative complications were not specifically categorized by Clavien grade, minor and clinically insignificant complications were likely omitted. This is evidenced by the reported Clavien grade 1-2 complication rates ranging from 3.1 to 22.5 %, depending on the study. Additionally, standardized definitions across all studies did not exist for all minor complications.

Intraoperative Complications Intraoperative complications of RAPN include vascular and visceral injury from laparoscopic access as well as hemorrhage and injury to adjacent structures, which may require conversion to laparoscopic, open, or radical nephrectomy. Access to the peritoneal cavity or retroperitoneal space with insufflation is necessary to achieve a working area for robotic surgery. Several techniques used to achieve

Curr Urol Rep (2014) 15:377

laparoscopic access include classic pneumoperitoneum (Veress needle), open (Hasson) entry, direct trocar insertion, radially expanding trocars, and visual entry systems. Minor complications associated with access include extraperitoneal insufflation and skin or subcutaneous bleeding. Major complications include vascular or gastrointestinal injury as well as bladder, ureteral or solid organ perforation. A meta-analysis of laparoscopic entry techniques found vascular injuries to occur in 0.1 % and bowel injuries in 0.18 % of cases [17•]. Many retrospective and randomized controlled trials have attempted to identify the safest method of laparoscopic access. The updated meta-analysis of 28 randomized control trials with 4860 patients evaluating the various methods of access showed no advantage of any technique in preventing major complications [17•]. Using an open entry technique did reduce the incidence of failed entry, extraperitoneal insufflation, and omental injury but did not demonstrate lower vascular or visceral injury rates. Although RAPN is safe, the largest studies (Table 1) reported an intraoperative hemorrhage in 18 patients out of 2118 cases (0.8 %). The described causes are renal veinotomy, injury to the inferior vena cava (IVC), trocar injury to the inferior mensenteric artery (IMA), splenic laceration and renal hemorrhage from an unidentified unclamped renal artery. Likewise, injury to adjacent structures including bowel, spleen, liver, and pancreas was reported in five patients (0.2 %). Conversion to traditional laparoscopic partial nephrectomy (PN) or radical nephrectomy (RN )is also a rare event, reported in only 19 patients (0.8 %). Conversions were required for a wide variety of reasons including positive surgical margins, satellite lesions, perinephric scarring, indeterminate ultrasound tumor localization, and an endophytic tumor not amenable to NSS.

Postoperative Complications Conventional Many of the postoperative complications following RAPN are not unique to kidney surgery or use of robotic techniques. These conventional postoperative complications can be separated broadly into potentially life threatening and non-life threatening. The common non-life threatening complications following RAPN include gastrointestinal, pulmonary, and wound-related complications. Tanagho et al., Spana et al., and Rogers et al. ,have reported similar rates of ileus after RAPN: 1.2 % (11/886), 1.1 % (5/450), and 2.0 % (3/148), respectively [9••, 12, 16]. Many other contemporary studies, however, do not list ileus as a postoperative complication. The significantly decreased rate of ileus following laparoscopic

Curr Urol Rep (2014) 15:377

Page 3 of 7, 377

Table 1 Summary of RAPN perioperative complications by study Study

Number of patients

Years enrolled

Intraop. complication rate

Conversion to PN (non-RAPN)

Conversion to RN

Postop. complication rate Clavien 1-2

Clavien 3-4

Clavien 5

Tanagho et al., 2013 [9••]

886

2007-2011

2.6 %

0.3 %

0.5 %

12.1 %

3.6 %

0%

Mathieu et al., 2013 [10] Ficarra et al., 2012 [11] Spana et al., 2011 [12] Kaouk et al., 2011 [13] Benway et al., 2010 [14] Scoll et al., 2010 [15] Rogers et al., 2008 [16]

240 347 450 252 183 100 148

2009-2011 2008-2010 2006-2009 2007-2010 2006-2008 2007-2009 2002-2007

n/a 2.9 1.8 2.0 2.7 n/a n/a

n/a 0% 0.7 % 2.0 % 1.1 % 1.0 % 1.4 %

n/a 0.6 % 1.6 % 0% 0% 1.0 % 0%

22.5 % 8.9 % 12.0 % 16.7 % 3.8 % 7.0 % 6.8 %

10.4 % 2.9 % 3.8 % 2.4 % 3.3 % 5.0 % 2.0 %

0% 0% 0% 0% 0% 1.0 % 0%

% % % %

intraop. = intraoperative, PN = partial nephrectomy, RN = radical nephrectomy, postop. = postoperative

approaches to nephrectomy, likely a result of decreased narcotic pain medication requirement and early ambulation, have been previously reported [18]. The same benefit is likely afforded to robotic approaches to nephrectomy. Non-life threatening pulmonary complications following RAPN, including dyspnea, atelectasis, pulmonary edema, and pneumonia, occurred at similar rates to ileus. Tanagho et al., Spana et al., and Kaouk et al., report these pulmonary complication rates as 1.4 % (12/886), 1.3 % (6/450), and 0.4 % (1/252), respectively [9••, 12, 13]. Wound-related complications, including local infection and hernia, occurred even less frequently. Tanagho et al., Spana et al., Kaouk et al., and Benway et al., report wound-related complication rates of 0.8 % (7/886), 0.7 % (3/450), 0.8 % (2/252), and 0.5 % (1/ 183), respectively [9••, 12–14]. Overall, the conventional nonlife threatening postoperative complications common to most abdominal surgeries occur at a relatively low frequency following RAPN. Thrombosis and cardiovascular events comprise the majority of potentially life-threatening postoperative complications common to abdominal surgery. Although urologic patients are typically of advanced age, cardiovascular postoperative complications following urologic surgery are relatively few compared to other surgical series [19]. Furthermore, cardiovascular events including arrhythmia and myocardial infarction (MI) are rare following RAPN. Tanagho et al., reports MI in 0.1 % (1/886) and arrhythmia in 0.5 % (4/886) of patients [9••]. Ficarra et al., reports MI in 0.3 % (1/347) and arrhythmia in 1.2 % (4/347) of patients [11]. Multiple studies including those by Spana et al., Kaouk et al., and Mathieu et al., report no occurrences of postoperative MI. Only one fatal postoperative MI is reported among the contemporary studies, occurring in the operating room during port site closure [15]. Likely the low cardiovascular complication rate of RAPN reflects the largely elective nature of the surgery, as the majority of tumors treated with RAPN are low stage [13–16].

The risk of thrombosis and thromboembolic complications following laparoscopic surgery has been well documented [20]. Although prevention strategies have diminished the incidence of postoperative thrombosis after urologic laparoscopic surgery [21], the risk of thromboembolic complications after RAPN is not negligible. For instance, pulmonary embolism was reported in 0.6 % (5/886), 1.6 % (7/450), 1.2 % (3/ 252), 2.0 % (2/100), and 1.4 % (2/148) of patients in contemporary series [9••, 12, 13, 15, 16]. Specific to Nephron-Sparing Surgery Although RAPN provides some technical benefits over LPN, the NSS-specific postoperative complications are common to both modalities [7, 22]. Specifically, these include bleeding complications requiring transfusion and/or additional procedures, urinary leakage as a result of collecting system violation, renal injury possibly related to warm ischemia time, and rarely, port-site metastases. Some of these NSS-specific complications are summarized in Table 2. Bleeding represents the most common postoperative complication following RAPN [9••, 10–16]. Postoperative bleeding complications following RAPN, including hematoma, hemorrhage, and pseudoaneurysm, ranged from 0.7 % to 12.3 % dependent on study [9••, 10–16]. Detection of postoperative hemorrhage is often driven by clinical presentation and confirmed by serial laboratory monitoring. As the larger series included in Table 2 show, postoperative bleeding requiring transfusion occurred in roughly 4 % of cases (4.2 % Tanagho et al., 3.7 % Ficarra et al., 4.2 % Spana et al.) [9••, 11, 12]. Postoperative transfusion rates following LPN are similar, with large studies reporting rates of 2.7 % and 4.5 % [23, 24]. Postoperative transfusion rate was substantially higher in the series reported by Kaouk et al., at 11.5 % [13]. Presumably, this represents a difference in transfusion criteria by institution rather than a difference in clinically significant bleeding.

377, Page 4 of 7

Curr Urol Rep (2014) 15:377

Table 2 Summary of NSS-specific postoperative complications following RAPN by study Study

Number of patients

Bleeding

Requiring transfusion

Pseudoaneurysm

Urine leak

Renal failure

Requiring hemodialysis

Tanagho et al., 2013 [9••] Mathieu et al., 2013 [10] Ficarra et al., 2012 [11] Spana et al., 2011 [12]

886 240 347 450

5.8 8.3 5.2 5.6

4.2 % n/a 3.7 % 4.2 %

1.1 3.8 1.4 0.2

%* % %* %

1.1 1.3 0.6 1.6

% % % %

0.7 % n/a 0% 0.2 %

0.2 % n/a 0% n/a

Kaouk et al., 2011 [13] Benway et al., 2010 [14] Scoll et al., 2010 [15] Rogers et al., 2008 [16]

252 183 100 148

12.3 % 3.8 % 3.0 % 0.7 %

11.5 % 1.1 % 3.0 % 0%

0.8 %* 1.6 % 1.0 % 0%

1.6 1.1 2.0 1.4

% % % %

0.8 % 0% 0% 0%

0.4 % 0% 0% 0%

% % % %

*bleeding requiring angioembolization was used as a surrogate for pseudoaneurysm

Although renal pseudoaneurysm following PN is traditionally considered a rare complication [25], it is more strongly associated with minimally invasive PN [26]. Reported rates of pseudoaneurysm following RAPN ranged from 0.2 % to 3.8 % depending on the study [9••, 10–16]. Although pseudoaneurysm was not specifically mentioned by Tanagho et al., Ficarra et al., and Kaouk et al., delayed hemorrhage requiring angioembolization was considered a surrogate. Typically, renal pseudoaneurysm presents as delayed gross hematuria and is associated with the treatment of centralized tumors [26, 27]. The gold standard for diagnosis and treatment of renal pseudoaneurysm remains selective angiography and embolization. Postoperative urinary leakage occurs as a result of collecting system violation during tumor excision and is specific to PN. Clinically, urine leak following RAPN may present as ileus, abdominal distention, electrolyte derangement, or increased surgical drain output. When no percutaneous drain was placed intraoperatively, management requires procedural intervention, such as ureteral stent, percutaneous drain, or percutaneous nephrostomy. Reported rates of urine leak following RAPN ranged from 0.6 % to 2.0 % depending on study [9••, 10–16], which was similar to reported urine leak rates following LPN in two large studies (1.9 % and 2.0 %) [23, 24]. Extrapolating from LPN studies, urine leak after RAPN is likely more common following resection of larger and deeper tumors [28, 29]. All of the reported urine leakage complications were successfully managed with percutaneous or ureteral drainage and did not require renal re-operation [9••, 10–16]. Reported rates of postoperative renal insufficiency were overall low, ranging from 0 % to 0.8 % depending on the study [9••, 11–16]. Although standardized definitions of postoperative renal insufficiency based on objective measures such as change in urine output or serum creatinine were not given, clinically significant postoperative renal insufficiency requiring hemodialysis was correspondingly low, ranging from 0 % to 0.4 % depending on the study [9••, 11, 13–16].

The decreased incidence of renal failure following RAPN may be a result of diminished warm ischemia time (WIT) as compared to LPN [7]. Higher WIT has been associated with renal functional deterioration following PN in the short and long term [30]. However, given that functional outcomes after PN are also strongly correlated to non-modifiable factors such as amount of renal parenchyma excised and baseline renal function [31, 32], the decreased incidence of renal failure following RAPN may represent patient selection. Port-site metastasis (PSM) is an exceedingly rare complication of laparoscopic oncologic surgery. The most recent review of the literature on renal cell carcinoma PSM reports nine previous cases following laparoscopic RN or PN and the first instance of renal cell carcinoma PSM following RAPN. Confirming previous reviews, the review states that contributing factors to PSM occurrence include patient immunosuppression, biologic aggressiveness of the tumor, and techniquerelated factors such as specimen morcellation and failure to use an entrapment bag [33].

Factors Predictive of Complications As expected with any surgical approach, perioperative outcomes improve with increased surgeon experience. Mottrie et al., demonstrated that progression of the surgeon learning curve was associated with decreased WIT, total operative time, and estimated blood loss (EBL) [34]. The improvement in perioperative measures with increased experience translates to decreased perioperative complication rate, as surgeons new to RAPN are likely to experience twofold to threefold higher complication rates. Mathieu et al. and Ficarra et al. demonstrated that the hazard ratio for perioperative complications was 2.14 and 2.99 for the first 20 and 30 cases in a surgeon's experience, respectively [10, 11]. Although increasing surgeon experience diminishes the risk, non-modifiable baseline patient characteristics also contribute to the likelihood of perioperative complications. Often

Curr Urol Rep (2014) 15:377

advanced age is used as a surrogate for baseline comorbidity and is assumed to correlate with complication risk. However, Hillyer et al., demonstrated in a matched cohort study that age greater than 70 years does not correlate with an increased risk of perioperative complications [35]. Patient body-mass index (BMI) provides a rough measure of baseline comorbidity and increases the technical difficulty of RAPN and may predispose the patient to more complications [36]. However, multiple studies have demonstrated no significant association between perioperative complications and BMI for patients undergoing RAPN. Naeem et al., demonstrated no significant difference in complications between patients based on BMI less than or greater than 30 kg/m2 [37]. Kiziloz et al., and Isac et al., found no significant difference in complications when patients were further sub-stratified into categories based on ranges of BMI [38, 39]. However, all three studies demonstrated a significant association between higher BMI and increased EBL [37–39]. Gorin et al., may have clarified the distinction by demonstrating that BMI and outer abdominal fat are not associated with increased complication rate, whereas increasing intraabdominal fat is significantly associated with complications [40]. Recently developed grading systems for renal tumors considered for PN include the RENAL nephrometry score [41] and PADUA classification [42]. Both grading systems have been validated as independent predictors of complications following PN, with four times greater odds of complication when the RENAL score is 9 or greater and when the PADUA classification is 10 or greater [43]. Specific to RAPN, increasing RENAL score appears to be associated with higher overall complication rates and major complication rates. Tanagho et al., found that in patients undergoing RAPN, RENAL scores of 4-6, 7-9, and 10-12 resulted in complication rates of 11, 18, and 23 %, respectively [9]. Simhan et al., found that, in patients undergoing PN, of which roughly half underwent RAPN, RENAL scores of 4-6, 7-9, and 10-12 resulted in major complication rates of 6, 11, and 22 %, respectively [44]. Nevertheless, the RENAL score may not be a strong predictor of complications following RAPN, as the correlation found by Tanagho et al., was small (OR=1.18) and other studies have found no significant association between RENAL score and RAPN perioperative complications [9••]. Similarly, PADUA classification has been found to be a significant but weak predictor of complications following RAPN (OR=1.04) [11]. The decreased strength of correlation between anatomic renal tumor grading systems and complications for patients undergoing RAPN as compared to LPN or OPN may be a result of increased surgeon experience as well as a technical advantage of robotic approaches to PN. Additionally, individual components of the RENAL score and PADUA classification have been examined for association with complication rates. Patel et al., demonstrated that the

Page 5 of 7, 377

distinction between tumors equal to or less than 4 cm (stage T1a) and tumors greater than 4 cm did not predict occurrence of a perioperative complication after RAPN [45]. Both Tanagho et al., and Ficarra et al., demonstrated that tumor size, when evaluated as a continuous variable, has a small but statistically significant correlation to perioperative complications after RAPN [9••, 11]. Although the increased difficulty of renal dissection in the case of hilar tumors seems apparent, Dulabon et al., found that hilar tumor location was not significantly associated with complications after RAPN [46]. Other studies have demonstrated that tumor proximity to the collecting system is the characteristic most strongly correlated to complication rates, likely as a result of increased collecting system violation and associated sequela. Mathieu et al., found that collecting system violation had a threefold higher association with major complications [10]. While evaluating the RENAL score, Liu et al., noted that “N” or nearness to the collecting system was the only RENAL score component significantly associated with complications after RAPN and LPN [47].

Conclusions RAPN is a safe treatment modality that expands the application of minimally invasive surgery allowing the extirpation of more technically challenging renal masses compared to traditional laparoscopic surgery. As the experience with RAPN has grown, studies demonstrate a similar incidence and complication profile compared to LPN. While robotic surgery provides distinct technical advantages, including stereoscopic vision, improved articulation of instruments and fine movement, surgeon experience continues to be the greatest factor in reducing complications. The most common complication is bleeding, while the risk of a urine leak and renal failure are far less common. Renal tumor grading systems standardize the descriptive language of renal masses and allow a more accurate comparison of outcomes and complications. Future studies will continue to assess the ability of these grading systems to predict complications and allow continued refinement and understanding of robotic renal surgical techniques. Compliance with Ethics Guidelines Conflict of Interest Dr. Eric Kim, Dr. Jeffrey A. Larson, Dr. Michael Figenshau, and Dr. R. Sherburne Figenshau reported no potential conflicts of interest relevant to this article. Human and Animal Rights and Informed Consent This article does not contain any studies with human or animal subjects performed by any of the authors.

377, Page 6 of 7

References Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance 1. 2.

3.

4.

5.

6.

7.

8. 9.

10.

11.

12.

13.

14. 15.

16. 17.

18.

Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11–30. Kane CJ, Mallin K, Ritchey J, et al. Renal cell cancer stage migration: analysis of the national cancer data base. Cancer. 2008;113:78–83. Fergany AF, Hafez KS, Novick AC. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol. 2000;163:442–5. Thompson RH, Boorjan SA, Lohse CM, et al. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. Cancer. 2008;112: 511–20. Campbell SC, Novick AC, Belldegrun A, et al. Guideline for management of the clinical T1 renal mass. J Urol. 2009;182: 1271–9. Haseebuddin M, Benway BM, Cabello JM, et al. Robot-assisted partial nephrectomy: evaluation of learning curve for an experienced renal surgeon. J Endourol. 2009;24:57–61. Benway BM, Bhayani SB, Rogers CG, et al. Robot assisted partial nephrectomy versus laparoscopic partial nephrectomy for renal tumors: a multi-institutional analysis of perioperative outcomes. J Urol. 2009;182:866–72. Dindo D, Demartines N, Clavien PA. Classification of surgical complications. Ann Surg. 2004;240:205–13. •• Tanagho YS, Kaouk JH, Allaf ME, et al. Perioperative complications of robot-assisted partial nephrectomy: analysis of 886 patients at 5 United States centers. Urology. 2013;81:573–80. This manuscript is the largest patient cohort describing perioperative complications in robotic partial nephrectomy. Mathieu R, Verhoest G, Droupy S, et al. Predictive factors of complications after robot-assisted laparoscopic partial nephrectomy: a retrospective multicentre study. BJU Int. 2013;112:283–9. Ficarra V, Bhayani S, Porter J, et al. Predictors of warm ischemia time and perioperative complications in a multicenter, international series of robot-assisted partial nephrectomy. Eur Urol. 2012;61: 395–402. Spana G, Haber GP, Dulabon LM, et al. Complications after robotic partial nephrectomy at centers of excellence: multi-institutional analysis of 450 cases. J Urol. 2011;186:417–22. Kaouk JH, Hillyer SP, Autorino R, et al. 252 Robotic partial nephrectomies: evolving renorrhaphy technique and surgical outcomes at a single institution. Urology. 2011;78:1338–44. Benway BM, Bhayani SB, Rogers CG, et al. Robot-assisted partial nephrectomy: an international experience. Eur Urol. 2010;57:815–20. Scoll BJ, Uzzo RG, Chen DY, et al. Robot-assisted partial nephrectomy: a large single-institutional experience. Urology. 2010;75: 1328–34. Rogers CG, Menon M, Weise ES, et al. Robotic partial nephrectomy: a multi-institutional analysis. J Robot Surg. 2008;2:141–3. • Ahmad G, O’Flynn H, Duffy JM, et al. Laparoscopic entry techniques. Cochrane Database Syst Rev. 2012;15(2), CD006583. This meta-analysis summarizes the complication rates of the most common laparoscopic access techniques and demonstrates no difference in major complications. Dunn MD, Portis AJ, Shalhav AL, et al. Laparoscopic versus open radical nephrectomy: a 9-year experience. J Urol. 2000;164:1153–9.

Curr Urol Rep (2014) 15:377 19.

Eagle KA, Rihal CS, Mickel MC, et al. Cardiac risk of noncardiac surgery. Circulation. 1997;96:1882–7. 20. Catheline JM, Turner R, Gaillard JL, et al. Thromboembolism in laparoscopic surgery: risk factors and preventive measures. Surg Laparosc Endosc Percutan Tech. 1999;9:135–9. 21. Montgomery JS, Wolf JS. Venous thrombosis prophylaxis for urological laparoscopy: fractionated heparin versus sequential compression devices. J Urol. 2005;173:1623–6. 22. Aboumarzouk OM, Stein RJ, Eyraud R, et al. Robotic versus laparoscopic partial nephrectomy: a systematic review and metaanalysis. Eur Urol. 2012;62:1023–33. 23. Breda A, Stephanian SV, Lam JS, et al. Use of haemostatic agents and glues during laparoscopic partial nephrectomy: a multiinstitutional survey from the United States and Europe of 1347 cases. Eur Urol. 2007;52:798–803. 24. Simmons MN, Gill IS. Decreased complications of contemporary laparoscopic partial nephrectomy: use of a standardized reporting system. J Urol. 2007;177:2067–73. 25. Albani JM, Novick AC. Renal artery pseudoaneurysm after partial nephrectomy: three case reports and a literature review. Urology. 2003;62:227–31. 26. Jain S, Nyirenda T, Yates J, Munver R. Incidence of renal artery pseudoaneurysm following open and minimally invasive partial nephrectomy: a systematic review and comparative analysis. J Urol. 2013;189:1643–8. 27. Inci K, Cil B, Yazici S, et al. Renal artery pseudoaneurysm: complication of minimally invasive kidney surgery. J Endourol. 2010;24:149–54. 28. Zorn KC, Gong EM, Orvieto MA, et al. Impact of collectingsystem repair during laparoscopic partial nephrectomy. J Endourol. 2007;21:315–20. 29. Meeks JJ, Zhao LC, Navai N, et al. Risk factors and management of urine leaks after partial nephrectomy. J Urol. 2008;180:2375–8. 30. Thompson RH, Lane BR, Lohse CM, et al. Every minute counts when the renal hilum is clamped during partial nephrectomy. Eur Urol. 2010;58:340–5. 31. Lane BR, Russo P, Uzzo RG, et al. Comparison of cold and warm ischemia during partial nephrectomy in 660 solitary kidneys reveals predominant role of nonmodifiable factors in determining ultimate renal function. J Urol. 2011;185:421–7. 32. Thompson RH, Lane BR, Lohse CM, et al. Renal function after partial nephrectomy: effect of warm ischemia relative to quantity and quality of preserved kidney. Urology. 2012;79: 356–60. 33. Song JB, Tanagho YS, Kim EH, et al. Camera-port site metastasis of a renal-cell carcinoma after robot-assisted partial nephrectomy. J Endourol. 2013;27:732–9. 34. Mottrie A, De Naeyer G, Schatteman P, et al. Impact of the learning curve on perioperative outcomes in patients who underwent robotic partial nephrectomy for parenchymal renal tumours. Eur Urol. 2010;58:127–33. 35. Hillyer SP, Autorino R, Spana G, et al. Perioperative outcomes of robotic-assisted partial nephrectomy in elderly patients: a matchedcohort study. Urology. 2012;79:1063–7. 36. Gong EM, Orvieto MA, Lyon MB, et al. Analysis of impact of body mass index on outcomes of laparoscopic renal surgery. Urology. 2007;69:38–43. 37. Naeem N, Petros F, Sukumar S, et al. Robot-assisted partial nephrectomy in obese patients. J Endourol. 2011;25:101–5. 38. Kiziloz H, Dorin R, Finnegan KT, et al. The impact of body mass index on perioperative outcomes in robot assisted laparoscopic partial nephrectomy. J Endourol. 2013. [Online ahead of print; doi:10.1089/end.2012.0665]. 39. Isac WE, Autorino R, Hillyer SP, et al. The impact of body mass index on surgical outcomes of robotic partial nephrectomy. BJU Int. 2012;110:E997–1002.

Curr Urol Rep (2014) 15:377 Gorin MA, Mullins JK, Pierorazaio PM, et al. Increased intraabdominal fat predicts perioperative complications following minimally invasive partial nephrectomy. Urology. 2013;81:1225– 31. 41. Kutikov A, Uzzo RG. The R.E.N.A.L nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol. 2009;182:844–53. 42. Ficarra V, Novara G, Secco S, et al. Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery. Eur Urol. 2009;56:786–93. 43. Hew MN, Baseskioglu B, Barwari K, et al. Critical appraisal of the PADUA classification and assessment of the RENAL nephrometry

Page 7 of 7, 377

40.

44.

45. 46.

47.

score in patients undergoing partial nephrectomy. J Urol. 2011;186: 42–6. Simhan J, Smaldone MC, Tsai KJ, et al. Objective measures of renal mass anatomic complexity predict rates of major complications following partial nephrectomy. Eur Urol. 2011;60:724–30. Patel MN, Krane S, Bhandari A, et al. Robotic partial nephrectomy for renal tumors larger than 4 cm. Eur Urol. 2010;57:310–6. Dulabon LM, Kaouk JH, Haber GP, et al. Multi-institutional analysis of robotic partial nephrectomy for hilar versus nonhilar lesions in 446 consecutive cases. Eur Urol. 2011;59:325–30. Liu ZW, Olweny EO, Yin G, et al. Prediction of perioperative outcomes following minimally invasive partial nephrectomy: role of the R.E.N.A.L nephrometry score. World J Urol. 2013;31:1183–1189.

Perioperative complications of robot-assisted partial nephrectomy.

The incidence of renal cell carcinoma continues to increase with utilization of diagnostic abdominal imaging with migration towards a proportionally g...
190KB Sizes 0 Downloads 0 Views